Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO30384 | Combretum quadrangulare | Species | Combretaceae | Eukaryota | leaves | Khon Kaen, Thailand | 2006-AUG |
PMID[21265555] |
NPO5648 | Fritillaria ussuriensis | Species | Liliaceae | Eukaryota | UNPD* | |||
NPO3796 | Pseudomonas viridiflava | Species | Pseudomonadaceae | Bacteria | UNPD* | |||
NPO3212 | Bipolaris sorokiniana | Species | Pleosporaceae | Eukaryota | UNPD* | |||
NPO53 | Nephelium mutabile | Species | Sapindaceae | Eukaryota | UNPD* | |||
NPO2839 | Dovyalis abyssinica | Species | Salicaceae | Eukaryota | UNPD* | |||
NPO1905 | Fagraea fragrans | Species | Gentianaceae | Eukaryota | UNPD* | |||
NPO119 | Cyperus alopecuroides | Species | Cyperaceae | Eukaryota | UNPD* | |||
NPO5020 | Jasonia montana | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO4713 | Eucalyptus cordata | Species | Myrtaceae | Eukaryota | UNPD* | |||
NPO30384 | Combretum quadrangulare | Species | Combretaceae | Eukaryota | Leaves |
PMID[21265555] |
||
NPO28985 | Radix bupleuri | Species | Lymnaeidae | Eukaryota | TCMSP* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT517 | Cell Line | Panel NCI-60 (60 carcinoma cell lines) | Homo sapiens | GI50 | = | 1700 | nM | 9632366 |
NPT518 | Protein Complex | Tubulin | Homo sapiens | IC50 | = | 3000 | nM | 9632366 |
NPT782 | Protein Family | Tubulin | Bos taurus | Inhibition | = | 43 | % | 9632366 |
NPT782 | Protein Family | Tubulin | Bos taurus | Inhibition | = | 75 | % | 9632366 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 2 | ug/ml | 469554 |
NPT3892 | Individual Protein | Tumor necrosis factor receptor superfamily member 10B | Homo sapiens | FC | = | 6.7 | 21265555 | |
NPT196 | Cell Line | AGS | Homo sapiens | Activity | = | 27 | % | 21265555 |
NPT196 | Cell Line | AGS | Homo sapiens | Activity | = | 24 | % | 21265555 |
NPT2715 | Individual Protein | Receptor-type tyrosine-protein phosphatase S | Homo sapiens | Inhibition | = | -1.2 | % | 26602279 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC82325 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC279989 |
0.9932 | High Similarity | NPC236223 |
0.9932 | High Similarity | NPC179126 |
0.9932 | High Similarity | NPC78326 |
0.9932 | High Similarity | NPC270620 |
0.9931 | High Similarity | NPC125062 |
0.9931 | High Similarity | NPC200740 |
0.9931 | High Similarity | NPC54394 |
0.9931 | High Similarity | NPC252933 |
0.9863 | High Similarity | NPC123886 |
0.9863 | High Similarity | NPC55205 |
0.9862 | High Similarity | NPC149127 |
0.9862 | High Similarity | NPC188871 |
0.9862 | High Similarity | NPC286342 |
0.9797 | High Similarity | NPC266960 |
0.9797 | High Similarity | NPC43243 |
0.9797 | High Similarity | NPC265511 |
0.9797 | High Similarity | NPC245546 |
0.9796 | High Similarity | NPC58382 |
0.9796 | High Similarity | NPC162351 |
0.9795 | High Similarity | NPC236769 |
0.9795 | High Similarity | NPC133953 |
0.9795 | High Similarity | NPC50403 |
0.9795 | High Similarity | NPC28274 |
0.9795 | High Similarity | NPC260895 |
0.9793 | High Similarity | NPC137062 |
0.9793 | High Similarity | NPC287101 |
0.9793 | High Similarity | NPC223579 |
0.9793 | High Similarity | NPC52005 |
0.9793 | High Similarity | NPC183950 |
0.9793 | High Similarity | NPC270465 |
0.9793 | High Similarity | NPC159103 |
0.9793 | High Similarity | NPC87125 |
0.9732 | High Similarity | NPC305663 |
0.9732 | High Similarity | NPC287979 |
0.9732 | High Similarity | NPC203891 |
0.9732 | High Similarity | NPC176665 |
0.9732 | High Similarity | NPC163524 |
0.9732 | High Similarity | NPC101830 |
0.9732 | High Similarity | NPC110070 |
0.973 | High Similarity | NPC44079 |
0.973 | High Similarity | NPC201451 |
0.973 | High Similarity | NPC26227 |
0.9726 | High Similarity | NPC50728 |
0.9726 | High Similarity | NPC166753 |
0.9724 | High Similarity | NPC120464 |
0.9667 | High Similarity | NPC143828 |
0.9667 | High Similarity | NPC300943 |
0.9667 | High Similarity | NPC191459 |
0.9667 | High Similarity | NPC4481 |
0.9667 | High Similarity | NPC204854 |
0.9667 | High Similarity | NPC22472 |
0.9667 | High Similarity | NPC19687 |
0.9667 | High Similarity | NPC7846 |
0.9667 | High Similarity | NPC152166 |
0.9667 | High Similarity | NPC288669 |
0.9667 | High Similarity | NPC18607 |
0.9667 | High Similarity | NPC105242 |
0.9667 | High Similarity | NPC176300 |
0.9667 | High Similarity | NPC253634 |
0.9667 | High Similarity | NPC25495 |
0.9667 | High Similarity | NPC115798 |
0.9667 | High Similarity | NPC9609 |
0.9667 | High Similarity | NPC261004 |
0.9667 | High Similarity | NPC18772 |
0.9667 | High Similarity | NPC130894 |
0.9664 | High Similarity | NPC100916 |
0.9664 | High Similarity | NPC55619 |
0.9664 | High Similarity | NPC247017 |
0.9664 | High Similarity | NPC49824 |
0.9664 | High Similarity | NPC200388 |
0.9664 | High Similarity | NPC98661 |
0.9664 | High Similarity | NPC292107 |
0.966 | High Similarity | NPC76376 |
0.9658 | High Similarity | NPC48479 |
0.9658 | High Similarity | NPC177298 |
0.9655 | High Similarity | NPC108406 |
0.9655 | High Similarity | NPC12200 |
0.96 | High Similarity | NPC78302 |
0.96 | High Similarity | NPC224137 |
0.96 | High Similarity | NPC472438 |
0.96 | High Similarity | NPC7973 |
0.96 | High Similarity | NPC189179 |
0.96 | High Similarity | NPC75215 |
0.96 | High Similarity | NPC29841 |
0.96 | High Similarity | NPC471515 |
0.96 | High Similarity | NPC174908 |
0.96 | High Similarity | NPC227192 |
0.96 | High Similarity | NPC235215 |
0.96 | High Similarity | NPC471479 |
0.96 | High Similarity | NPC93376 |
0.9597 | High Similarity | NPC80534 |
0.9597 | High Similarity | NPC133392 |
0.9597 | High Similarity | NPC56786 |
0.9597 | High Similarity | NPC32557 |
0.9597 | High Similarity | NPC189960 |
0.9597 | High Similarity | NPC214138 |
0.9595 | High Similarity | NPC187498 |
0.9595 | High Similarity | NPC83508 |
0.9595 | High Similarity | NPC241498 |
0.9595 | High Similarity | NPC198826 |
0.9595 | High Similarity | NPC275722 |
0.9595 | High Similarity | NPC301323 |
0.9595 | High Similarity | NPC100887 |
0.9595 | High Similarity | NPC212678 |
0.9595 | High Similarity | NPC39732 |
0.9595 | High Similarity | NPC222830 |
0.9595 | High Similarity | NPC239128 |
0.9595 | High Similarity | NPC131624 |
0.9595 | High Similarity | NPC293183 |
0.9595 | High Similarity | NPC304954 |
0.9595 | High Similarity | NPC256283 |
0.9595 | High Similarity | NPC57030 |
0.9595 | High Similarity | NPC162313 |
0.9595 | High Similarity | NPC120163 |
0.9595 | High Similarity | NPC71334 |
0.9595 | High Similarity | NPC156222 |
0.9595 | High Similarity | NPC301123 |
0.9595 | High Similarity | NPC275836 |
0.9595 | High Similarity | NPC60972 |
0.9595 | High Similarity | NPC188203 |
0.9595 | High Similarity | NPC25270 |
0.9592 | High Similarity | NPC219330 |
0.9589 | High Similarity | NPC195202 |
0.9589 | High Similarity | NPC261548 |
0.9586 | High Similarity | NPC20791 |
0.9586 | High Similarity | NPC179271 |
0.9536 | High Similarity | NPC193842 |
0.9533 | High Similarity | NPC326037 |
0.9533 | High Similarity | NPC474520 |
0.9533 | High Similarity | NPC13858 |
0.9533 | High Similarity | NPC268161 |
0.9533 | High Similarity | NPC320825 |
0.9533 | High Similarity | NPC178854 |
0.9533 | High Similarity | NPC471500 |
0.953 | High Similarity | NPC246204 |
0.953 | High Similarity | NPC274327 |
0.953 | High Similarity | NPC145379 |
0.953 | High Similarity | NPC69394 |
0.953 | High Similarity | NPC176775 |
0.953 | High Similarity | NPC255350 |
0.953 | High Similarity | NPC183878 |
0.953 | High Similarity | NPC47781 |
0.953 | High Similarity | NPC160951 |
0.953 | High Similarity | NPC22519 |
0.953 | High Similarity | NPC86485 |
0.953 | High Similarity | NPC231018 |
0.9527 | High Similarity | NPC225731 |
0.9521 | High Similarity | NPC74881 |
0.9521 | High Similarity | NPC62536 |
0.9521 | High Similarity | NPC33265 |
0.9521 | High Similarity | NPC51443 |
0.9474 | High Similarity | NPC246478 |
0.947 | High Similarity | NPC67876 |
0.947 | High Similarity | NPC52530 |
0.9467 | High Similarity | NPC2476 |
0.9467 | High Similarity | NPC213622 |
0.9467 | High Similarity | NPC4455 |
0.9467 | High Similarity | NPC227325 |
0.9467 | High Similarity | NPC146165 |
0.9467 | High Similarity | NPC138360 |
0.9467 | High Similarity | NPC280339 |
0.9467 | High Similarity | NPC92659 |
0.9467 | High Similarity | NPC20830 |
0.9467 | High Similarity | NPC183597 |
0.9467 | High Similarity | NPC128863 |
0.9467 | High Similarity | NPC163780 |
0.9467 | High Similarity | NPC50715 |
0.9467 | High Similarity | NPC201136 |
0.9467 | High Similarity | NPC196439 |
0.9467 | High Similarity | NPC167815 |
0.9467 | High Similarity | NPC256612 |
0.9463 | High Similarity | NPC37684 |
0.9463 | High Similarity | NPC142540 |
0.9463 | High Similarity | NPC219582 |
0.9463 | High Similarity | NPC302950 |
0.9463 | High Similarity | NPC27208 |
0.9463 | High Similarity | NPC236637 |
0.9463 | High Similarity | NPC63187 |
0.9463 | High Similarity | NPC471982 |
0.9463 | High Similarity | NPC157784 |
0.9459 | High Similarity | NPC184136 |
0.9459 | High Similarity | NPC306821 |
0.9456 | High Similarity | NPC119059 |
0.9452 | High Similarity | NPC169749 |
0.9452 | High Similarity | NPC310259 |
0.9448 | High Similarity | NPC279121 |
0.9408 | High Similarity | NPC55738 |
0.9408 | High Similarity | NPC280680 |
0.9408 | High Similarity | NPC195832 |
0.9404 | High Similarity | NPC474638 |
0.9404 | High Similarity | NPC153512 |
0.9404 | High Similarity | NPC250922 |
0.94 | High Similarity | NPC75279 |
0.94 | High Similarity | NPC18727 |
0.94 | High Similarity | NPC276409 |
0.94 | High Similarity | NPC141212 |
0.94 | High Similarity | NPC250822 |
0.9396 | High Similarity | NPC31363 |
0.9396 | High Similarity | NPC59162 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC82325 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9586 | High Similarity | NPD1512 | Approved |
0.953 | High Similarity | NPD2801 | Approved |
0.9463 | High Similarity | NPD1934 | Approved |
0.9448 | High Similarity | NPD1511 | Approved |
0.9404 | High Similarity | NPD3882 | Suspended |
0.9338 | High Similarity | NPD3817 | Phase 2 |
0.9145 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.9108 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.9108 | High Similarity | NPD6166 | Phase 2 |
0.9108 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8993 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8944 | High Similarity | NPD6797 | Phase 2 |
0.8889 | High Similarity | NPD7251 | Discontinued |
0.8834 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8834 | High Similarity | NPD7808 | Phase 3 |
0.882 | High Similarity | NPD7054 | Approved |
0.8765 | High Similarity | NPD7472 | Approved |
0.8758 | High Similarity | NPD3818 | Discontinued |
0.8675 | High Similarity | NPD6799 | Approved |
0.865 | High Similarity | NPD7074 | Phase 3 |
0.8608 | High Similarity | NPD7075 | Discontinued |
0.8535 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8523 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8523 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8514 | High Similarity | NPD1510 | Phase 2 |
0.8471 | Intermediate Similarity | NPD6801 | Discontinued |
0.8467 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8462 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8428 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8375 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8367 | Intermediate Similarity | NPD1240 | Approved |
0.8365 | Intermediate Similarity | NPD5402 | Approved |
0.8364 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8344 | Intermediate Similarity | NPD6599 | Discontinued |
0.8333 | Intermediate Similarity | NPD1247 | Approved |
0.8333 | Intermediate Similarity | NPD2796 | Approved |
0.8323 | Intermediate Similarity | NPD919 | Approved |
0.8282 | Intermediate Similarity | NPD6232 | Discontinued |
0.8272 | Intermediate Similarity | NPD5494 | Approved |
0.8269 | Intermediate Similarity | NPD5403 | Approved |
0.8258 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8258 | Intermediate Similarity | NPD5401 | Approved |
0.8255 | Intermediate Similarity | NPD1607 | Approved |
0.8243 | Intermediate Similarity | NPD943 | Approved |
0.8242 | Intermediate Similarity | NPD7473 | Discontinued |
0.8224 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8187 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8155 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.8121 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8095 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8075 | Intermediate Similarity | NPD7819 | Suspended |
0.8027 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8026 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.8025 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD3750 | Approved |
0.8 | Intermediate Similarity | NPD1613 | Approved |
0.795 | Intermediate Similarity | NPD7411 | Suspended |
0.7947 | Intermediate Similarity | NPD230 | Phase 1 |
0.7947 | Intermediate Similarity | NPD447 | Suspended |
0.7929 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7892 | Intermediate Similarity | NPD6959 | Discontinued |
0.7857 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7821 | Intermediate Similarity | NPD2800 | Approved |
0.7812 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.78 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7798 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7791 | Intermediate Similarity | NPD6559 | Discontinued |
0.7765 | Intermediate Similarity | NPD3751 | Discontinued |
0.7748 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7742 | Intermediate Similarity | NPD2935 | Discontinued |
0.7722 | Intermediate Similarity | NPD6190 | Approved |
0.7712 | Intermediate Similarity | NPD1933 | Approved |
0.7711 | Intermediate Similarity | NPD3749 | Approved |
0.7677 | Intermediate Similarity | NPD3748 | Approved |
0.7667 | Intermediate Similarity | NPD9494 | Approved |
0.7658 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7651 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7647 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7635 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7633 | Intermediate Similarity | NPD3787 | Discontinued |
0.7625 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7595 | Intermediate Similarity | NPD1243 | Approved |
0.7595 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7593 | Intermediate Similarity | NPD920 | Approved |
0.758 | Intermediate Similarity | NPD2344 | Approved |
0.7578 | Intermediate Similarity | NPD2533 | Approved |
0.7578 | Intermediate Similarity | NPD2534 | Approved |
0.7578 | Intermediate Similarity | NPD2532 | Approved |
0.7574 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7547 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7546 | Intermediate Similarity | NPD1653 | Approved |
0.7533 | Intermediate Similarity | NPD1203 | Approved |
0.7516 | Intermediate Similarity | NPD6099 | Approved |
0.7516 | Intermediate Similarity | NPD6100 | Approved |
0.7516 | Intermediate Similarity | NPD2313 | Discontinued |
0.75 | Intermediate Similarity | NPD3226 | Approved |
0.7469 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7466 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7456 | Intermediate Similarity | NPD6234 | Discontinued |
0.7453 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7452 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7443 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD6651 | Approved |
0.7432 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7416 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7403 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7403 | Intermediate Similarity | NPD6798 | Discontinued |
0.7391 | Intermediate Similarity | NPD2309 | Approved |
0.7389 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7383 | Intermediate Similarity | NPD422 | Phase 1 |
0.7372 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7358 | Intermediate Similarity | NPD2346 | Discontinued |
0.7355 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7342 | Intermediate Similarity | NPD2799 | Discontinued |
0.7341 | Intermediate Similarity | NPD2403 | Approved |
0.7333 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7333 | Intermediate Similarity | NPD9717 | Approved |
0.733 | Intermediate Similarity | NPD5953 | Discontinued |
0.7314 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7301 | Intermediate Similarity | NPD7390 | Discontinued |
0.729 | Intermediate Similarity | NPD3268 | Approved |
0.7288 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7284 | Intermediate Similarity | NPD2354 | Approved |
0.7273 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7273 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7267 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7267 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7262 | Intermediate Similarity | NPD37 | Approved |
0.7261 | Intermediate Similarity | NPD6355 | Discontinued |
0.7255 | Intermediate Similarity | NPD2798 | Approved |
0.7241 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7237 | Intermediate Similarity | NPD3225 | Approved |
0.7235 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7235 | Intermediate Similarity | NPD4965 | Approved |
0.7235 | Intermediate Similarity | NPD4966 | Approved |
0.7233 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7233 | Intermediate Similarity | NPD7033 | Discontinued |
0.7222 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD1608 | Approved |
0.7208 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7197 | Intermediate Similarity | NPD4060 | Phase 1 |
0.719 | Intermediate Similarity | NPD2797 | Approved |
0.7184 | Intermediate Similarity | NPD5242 | Approved |
0.7182 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7179 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD411 | Approved |
0.7162 | Intermediate Similarity | NPD5536 | Phase 2 |
0.716 | Intermediate Similarity | NPD2654 | Approved |
0.7159 | Intermediate Similarity | NPD2163 | Approved |
0.7159 | Intermediate Similarity | NPD7228 | Approved |
0.7143 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7135 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7135 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7115 | Intermediate Similarity | NPD7095 | Approved |
0.7103 | Intermediate Similarity | NPD228 | Approved |
0.7101 | Intermediate Similarity | NPD6386 | Approved |
0.7101 | Intermediate Similarity | NPD6385 | Approved |
0.7091 | Intermediate Similarity | NPD4357 | Discontinued |
0.7078 | Intermediate Similarity | NPD3266 | Approved |
0.7078 | Intermediate Similarity | NPD3267 | Approved |
0.7076 | Intermediate Similarity | NPD4288 | Approved |
0.7076 | Intermediate Similarity | NPD5353 | Approved |
0.7067 | Intermediate Similarity | NPD9268 | Approved |
0.7059 | Intermediate Similarity | NPD6844 | Discontinued |
0.7059 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7059 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7055 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7048 | Intermediate Similarity | NPD3688 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7048 | Intermediate Similarity | NPD3146 | Approved |
0.7048 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD4340 | Discontinued |
0.7039 | Intermediate Similarity | NPD1201 | Approved |
0.7037 | Intermediate Similarity | NPD6781 | Approved |
0.7037 | Intermediate Similarity | NPD2353 | Approved |
0.7037 | Intermediate Similarity | NPD6777 | Approved |
0.7037 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD6779 | Approved |
0.7037 | Intermediate Similarity | NPD6780 | Approved |
0.7037 | Intermediate Similarity | NPD6776 | Approved |
0.7037 | Intermediate Similarity | NPD6778 | Approved |
0.7037 | Intermediate Similarity | NPD6782 | Approved |
0.7029 | Intermediate Similarity | NPD5710 | Approved |
0.7029 | Intermediate Similarity | NPD5711 | Approved |
0.7025 | Intermediate Similarity | NPD4062 | Phase 3 |
0.702 | Intermediate Similarity | NPD17 | Approved |
0.7017 | Intermediate Similarity | NPD8313 | Approved |
0.7017 | Intermediate Similarity | NPD8312 | Approved |
0.7016 | Intermediate Similarity | NPD7435 | Discontinued |
0.7006 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7006 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7005 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7005 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7 | Intermediate Similarity | NPD9545 | Approved |
0.6995 | Remote Similarity | NPD8150 | Discontinued |
0.6995 | Remote Similarity | NPD7584 | Approved |
0.6993 | Remote Similarity | NPD2981 | Phase 2 |
0.6981 | Remote Similarity | NPD1558 | Phase 1 |
PubChem CID   | 5380905 |
ChEMBL   | CHEMBL309263 |
ZINC   |
Molecular Weight:   | 330.07 |
ALogP:   | -2.3282 |
MLogP:   | 2.56 |
XLogP:   | 1.363 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 105.45 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 3 |
# Heavy Atoms:   | 24 |